SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 200
- Registration Number
- NCT01434329
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
- Conditions
- Therapy-related ToxicityColorectal CancerDermatologic ComplicationsLung Cancer
- Interventions
- Procedure: assessment of therapy complicationsProcedure: psychosocial assessment and careProcedure: quality-of-life assessment
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 146
- Registration Number
- NCT01416688
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸Illinois CancerCare-Canton, Canton, Illinois, United States
🇺🇸Cancer Care Center of Decatur, Decatur, Illinois, United States
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 53
- Registration Number
- NCT01412879
- Locations
- 🇺🇸
Illinois CancerCare - Galesburg, Galesburg, Illinois, United States
🇺🇸Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States
🇺🇸Wenatchee Valley Medical Center, Wenatchee, Washington, United States
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy
- Conditions
- ArthralgiaBreast CancerPain
- Interventions
- Dietary Supplement: omega-3 fatty acidOther: placebo
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 262
- Registration Number
- NCT01385137
- Locations
- 🇺🇸
Providence Newberg Medical Center, Newberg, Oregon, United States
🇺🇸Baylor University Medical Center - Dallas, Dallas, Texas, United States
🇺🇸Hurley Medical Center, Flint, Michigan, United States
S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy
- Conditions
- Leukemia
- First Posted Date
- 2011-05-25
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 310
- Registration Number
- NCT01360125
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabOther: laboratory biomarker analysisRadiation: fludeoxyglucose F 18Radiation: selective external radiation therapyRadiation: yttrium Y 90 ibritumomab tiuxetanOther: R-CHOP regimen
- First Posted Date
- 2011-05-25
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 159
- Registration Number
- NCT01359592
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Bronson Methodist Hospital, Kalamazoo, Michigan, United States
🇺🇸St. Mary Mercy Hospital, Livonia, Michigan, United States
S0820, Adenoma and Second Primary Prevention Trial
- Conditions
- Colorectal Neoplasms
- Interventions
- First Posted Date
- 2011-05-09
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 354
- Registration Number
- NCT01349881
- Locations
- 🇺🇸
Alaska Women's Cancer Care, Anchorage, Alaska, United States
🇺🇸Alaska Regional Hospital, Anchorage, Alaska, United States
🇺🇸Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2011-04-20
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 290
- Registration Number
- NCT01338974
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 41
- Registration Number
- NCT01309672
- Locations
- 🇺🇸
Grant Medical Center Cancer Care, Columbus, Ohio, United States
🇺🇸Sletten Cancer Institute at Benefis Healthcare, Great Falls, Montana, United States
🇺🇸Kaiser Permanente Medical Center - Richmond, Richmond, California, United States
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
- Conditions
- Bladder Cancer
- Interventions
- Procedure: therapeutic conventional surgeryProcedure: therapeutic standard lymphadenectomyProcedure: therapeutic extended lymphadenectomy
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 658
- Registration Number
- NCT01224665
- Locations
- 🇨🇦
London Regional Cancer Program, London, Ontario, Canada
🇨🇦QEII Health Sciences Centre/Capital District Health Authority, Halifax, Nova Scotia, Canada
🇨🇦BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada